Major US hospital-based clinical trial highlights benefit of nasal decolonization to reduce ICU infections caused by Staphylococcus aureus
News
Monday October 18, 2021
Major US hospital-based clinical trial highlights benefit of nasal decolonization to red...
Destiny Pharma plc (“Destiny Pharma” or “the Company”) Major US hospital-based clinical trial highlights benefit of nasal decolonization to reduce ICU infections caused by Staphylococcus aureus Strong support for potential […]
Monday October 11, 2021
IDSA press release: Drug-resistant Infections Led to $1.9 Billion in Health Care Costs, ...
New IDSA release highlights the urgent need for action after antibiotic-resistant infections led to $1.9 billion in health care costs, and more than 10,000 deaths, among older adults in one […]